Day Gain | ||
Gain | ||
Market Val | ||
Costs | ||
Cash | ||
Portfolio | ||
Realized | ||
Dividend |
Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2024-11-07 | 2024-09 | 1.6 | N/A | N/A | N/A |
2024-08-01 | 2024-06 | 1.34 | 1.4 | 0.06 | 4.48% |
2024-05-02 | 2024-03 | 1.51 | 1.53 | 0.02 | 1.32% |
2024-02-01 | 2023-12 | 2.09 | 2.18 | 0.09 | 4.31% |
2023-11-02 | 2023-09 | 1.39 | 1.46 | 0.07 | 5.04% |
2023-08-03 | 2023-06 | 1.19 | 1.26 | 0.07 | 5.88% |
Date | Firm | Action | From | To |
---|---|---|---|---|
2023-10-31 | Wedbush | Upgrade | Outperform | Outperform |
2023-10-30 | Needham | Upgrade | Buy | Buy |
2023-10-29 | Keybanc | Upgrade | Sector Weight | |
2023-10-29 | Barclays | Upgrade | Equal-Weight | Equal-Weight |
2023-10-29 | Oppenheimer | Upgrade | Outperform | Outperform |
2023-10-23 | B of A Securities | Upgrade | Neutral | Neutral |
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2024-08-06 | ADAMS KATHERINE L | General Counsel | 187.04K | Stock Gift |
2024-04-01 | COOK TIMOTHY D | Chief Executive Officer | 3.28M | Sale |
2024-01-31 | JUNG ANDREA | Director | 74.49K | Conversion of Exercise of derivative security |
2024-08-14 | KONDO CHRISTOPHER | Officer | 15.42K | Sale |
2024-05-29 | LEVINSON ARTHUR D | Director | 4.42M | Sale |
2024-04-10 | MAESTRI LUCA | Chief Financial Officer | 107.79K | Sale |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Group Inc | 1.30B | 252.88B | 8.34% |
2023-06-29 | Blackrock Inc. | 1.04B | 201.66B | 6.65% |
2023-06-29 | Berkshire Hathaway, Inc | 915.56M | 177.59B | 5.86% |
2023-06-29 | State Street Corporation | 578.90M | 112.29B | 3.70% |
2023-06-29 | FMR, LLC | 307.07M | 59.56B | 1.96% |
2023-06-29 | Geode Capital Management, LLC | 291.54M | 56.55B | 1.86% |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Total Stock Market Index Fund | 465.99M | 90.39B | 2.98% |
2023-06-29 | Vanguard 500 Index Fund | 352.02M | 68.28B | 2.25% |
2023-08-30 | Fidelity 500 Index Fund | 169.38M | 31.82B | 1.08% |
2023-09-29 | SPDR S&P 500 ETF Trust | 165.19M | 28.28B | 1.06% |
2023-09-29 | iShares Core S&P 500 ETF | 138.98M | 23.80B | 0.89% |
2023-06-29 | Vanguard Growth Index Fund | 127.13M | 24.66B | 0.81% |
Dividend | Date |
---|---|
0.25 | 2024-08-12 |
0.25 | 2024-05-10 |
0.24 | 2024-02-09 |
0.24 | 2023-11-10 |
0.24 | 2023-11-09 |
0.24 | 2023-08-14 |
Split | Date |
---|---|
4 : 1 | 2020-08-31 |
7 : 1 | 2014-06-09 |
2 : 1 | 2005-02-28 |
2 : 1 | 2000-06-21 |
2 : 1 | 1987-06-16 |
-
-
Just got market watch headline!!! $$$$
-
-
-
-
-
-
-
-
-
-
$FIRE is undervalue right now. Bought 1000
-
-
Go Apple up up new braking the icar Kia big money signing this month February great news Apple is firing on all cylinders again big step in to the Icar electric go Tim Cook
-
Go Apple go Apple up up slowly up up let’s see 150 eow yes . People don’t listen to the negativity of the short sellers . Buy buy the best company in the world and had their best quarter ever go Apple ,history repeats itself again and again up up Apple has a fantastic balance sheet fact are fact up up buy buy buy
-
-
Go Apple go Apple let’s see 150 eow or before yes up up money money up up 150 plus plus up up
-
Saphyr Study Is First to Analyze Cancer Regulation at Level of Single DNA Molecules, Opens Promising New Avenue of Cancer Research
Publication on novel Saphyr based method to analyze DNA methylation in cancer genomes enables new field of cancer research and drug target discovery
Bionano Genomics
February 02, 2021 08:00 ET
SAN DIEGO, Feb. 02, 2021 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO), announced today the publication of a study that measured DNA methylation, the chemical modification of the DNA that controls gene regulation, of the various regions regulating cancer genes on single DNA molecules. The study led by Dr. Yuval Ebenstein at the Tel Aviv University found that optical genome mapping (OGM) with Bionano’s Saphyr system combined with a custom labeling method developed by the scientists was capable of analyzing regulatory regions that work together to turn cancer genes on and off over distances of hundreds of thousands of basepairs. The ability to measure these relationships on single DNA molecules is something that was previously impossible. Only Saphyr can detect these long-distance connections in methylation profiles because it’s the only technology that can generate such long-range, single molecule data at high throughput and coverage.While most of the important information in our genome is encoded in the sequence and the structural organization of the sequence, the regulation of genes is partially registered through chemical labels attached to the DNA. These chemical labels, called DNA methylation, can turn genes on and off at specific time points and in certain tissues. A normal cell can only become cancerous and grow excessively by making multiple changes to the genome and the way it is regulated. These changes include single nucleotide variations, structural variations and changes to DNA methylation patterns that can happen to the actual cancer gene, to the promoter region that switches the gene on and off, or to enhancer regions that can be hundreds of thousands of basepairs removed from the cancer gene. Studying these methylation patterns has been difficult or impossible because current methods only allow you to measure values averaged over dozens or hundreds of cells. To fully understand how cancer genes are turned on and off, it is important to measure the methylation status of a gene, its promoter, and its enhancers on individual, single molecules, which is impossible with short-read or long-read sequencing because their read lengths are insufficient.
The study by Dr. Ebenstein is the first to systematically analyze more than one hundred thousand promoter-enhancer pairs up to 200,000 basepairs apart, on millions of single molecules. This large dataset enabled them to correctly distinguish between normal and tumor cells with an error rate smaller than 1%.
Yuval Ebenstein, PhD, commented: “Long methylation reads at such high coverage just never existed before, mostly because Saphyr produces the highest fraction of the longest reads compared to any other platform. This dataset allows us to analyze long range information on the single-molecule level, which opens up a whole new avenue for complex disease specific epigenetic biomarkers. This study can be dramatic for early cancer diagnostics where the normal and cancer cells have a very similar genetic background but the extreme changes in enhancer methylation distinguish the cancer cells. This data may for the first time allow us to discover new biomarkers and point to novel drug targets in places of the genome where no one has looked before.”
Erik Holmlin, PhD, CEO of Bionano Genomics commented: “While Bionano Genomics is laser focused on bringing comprehensive, whole genome structural variation detection to the clinic, scientists around the world are pushing the boundaries of what our single molecule analysis system Saphyr can do. Dr. Ebenstein’s team has developed a novel application of our technology that contributes to solving unique scientific questions. The epigenetic regulation of cancer genes through DNA methylation of its promoters and enhancers has been difficult or impossible to study with current methods that are limited by short read lengths. We are excited about the possibilities for discoveries of novel diagnostics and treatments for cancer that this application enables.”
The publication is available at https://www.biorxiv.org/content/10.1101/2021.01.28.428654v1
-
Prediction: Apple (Nasdaq: AAPL) Stock Will Never Pass This Price
news.google.com • -
Apple, Nvidia Make One Elite List. This Breakout Stock Makes Two More.
news.google.com • -
Apple Inc. stock rises Tuesday, still underperforms market
news.google.com • -
(AAPL) Long Term Investment Analysis
news.google.com • -
10 Information Technology Stocks With Whale Alerts In Today's Session
news.google.com • -
3 reasons why investors should remain bullish on Apple stock – Needham
news.google.com • -
The Big 3: CAT, AAPL, PWR
youtube.com • -
Most ‘Magnificent Seven’ stocks are seeing declines in crowding
news.google.com • -
Skyworks: Still Pretending To Be A Blue Chip Stock (NASDAQ:SWKS)
news.google.com • -
Apple to hit $4 trillion in 2025, according to analyst
finbold.com • -
Here's just how much Apple's business is dependent on the iPhone
marketwatch.com • -
Williams Sonoma Stock Could Be Ripe for a Short at Current Levels
marketbeat.com • -
AAPL Quantitative Stock Analysis
news.google.com • -
Prediction: 1 Stock That Will Be Worth More Than Apple 10 Years From Now
news.google.com • -
Is It Too Late to Buy Apple Stock?
news.google.com • -
Is It Too Late to Buy Apple Stock?
fool.com • -
Is It Too Late to Buy Apple Stock?
news.google.com • -
Forget Apple: This Stock Has Made Far More Millionaires
news.google.com • -
Analysts rethink key Apple supplier stock price target
news.google.com • -
Apple Inc. stock underperforms Monday when compared to competitors
news.google.com • -
Apple Inc. stock underperforms Monday when compared to competitors
news.google.com • -
Apple iPhone 16 Early Demand Deemed Healthy
news.google.com • -
Apple Holds Off Microsft And Nvidia. Tesla's Mag 7 Card In Jeapordy.
news.google.com • -
Apple’s Late-Day Plunge Stirs Speculation Over Who Was Selling
news.google.com • -
Magnificent Seven Stocks To Buy And Watch
news.google.com • -
EU's Vestager on Apple, Google fines
youtube.com • -
Apple’s (AAPL) Q2 Relative Performance Dropped Despite Gains
news.google.com • -
Apple's iPhone 16 launch could spark AI-Driven 'super cycle', says investment bank
proactiveinvestors.co.uk • -
Is Apple Stock a Buy for MedTech Upside?
news.google.com • -
Wearable Devices Announces First Half 2024 Financial Results
globenewswire.com • -
Apple gets EU warning to open up iPhone operating system
techxplore.com • -
Is Apple stock about to rocket to $300?
finbold.com • -
APPLE INC : JP Morgan gives a Buy rating
news.google.com • -
APPLE INC : Receives a Buy rating from Goldman Sachs
news.google.com • -
Will New AI Integration Help Apple Stock Pop?
news.google.com • -
Apple: Risk From Trifold Smartphone Market
news.google.com • -
Where Will Apple Stock Be in 3 Years?
news.google.com • -
Apple Is the World’s Most Valuable Stock. It’s Still Underestimated.
news.google.com • -
Apple (AAPL) Dips More Than Broader Market: What You Should Know
news.google.com • -
Apple iPhone 16 Handsets Are Finally Out In The Wild
news.google.com • -
10 Information Technology Stocks Whale Activity In Today's Session
news.google.com • -
Stock market gains, new Nike CEO, Apple iPhone 16: 3 Things
news.google.com • -
Apple Stock Price Analysis: Strong Momentum Post-Product Launch
news.google.com • -
Apple Stock Rises On Reassuring iPhone 16 Sales Comments From T-Mobile
news.google.com • -
Apple Stock Sees RS Rating Improve To 77
news.google.com • -
10 Information Technology Stocks Whale Activity In Today's Session
news.google.com • -
AAPL: 3 High-Quality Tech Stocks to Hold for Long-Term Growth
news.google.com • -
Top analyst revisits Apple stock price target amid iPhone 16 debate
news.google.com • -
Is Apple Stock A Buy Amid Reports Of Lackluster iPhone 16 Preorders?
news.google.com •
clickable symbol $AAPL
clickable link https://finabase.io/symbol/aapl